Smac与肿瘤(4)
[7] WORFB B,GREEND R.Suicidal tendencies:apoptotic cell death by caspase family proteinases.BiolChem,1999,274(29):20049-20052.
[8] Soane L,Cho HJ,Niculescu F,et al.C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway.Immunol,2001,167(4):2305.
[9] Soane L,Rus H,Niculescu F,et al.Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation.Immunol,1999,163(11):6132.
[10] Hila S,Soane L,Koski CL,et al.Sublytic C5b-9-stimulated Schwann cell survival through PI 3-kinase-mediated phosphorylation of BAD.Glia,2001,36(1):58.
[11] Niculescu F,Rus H.Complement activation and atherosclerosis.Mol Immunol,1999,36(13-14):949.
[12] Tanhehco EJ,Lee H,Lucchesi BR.Sublytic complement attack reduces infarct size in rabbit isolated hearts:evidence for C5a-mediated cardioprotection.Immunopharmacology,2000,49(3):391.
[13] Kraus S,Seger R,Fishelson Z.Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis.Clin Exp Immunol,2001,123(3):366.
[14] Kraus S,Fishelson Z.Cell desensitization by sublytic C5b-9 complexes and calcium ionophores depends on activation of protein kinase C.Eur J Immunol,2000,30(5):1272.
[15] Hed J.Role of complement in immune or idiopathic thrombocytopenic purpura.Acta Paediatr Suppl,1998,424:37., 百拇医药(郭 伟 李惠翔)
[8] Soane L,Cho HJ,Niculescu F,et al.C5b-9 terminal complement complex protects oligodendrocytes from death by regulating Bad through phosphatidylinositol 3-kinase/Akt pathway.Immunol,2001,167(4):2305.
[9] Soane L,Rus H,Niculescu F,et al.Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation.Immunol,1999,163(11):6132.
[10] Hila S,Soane L,Koski CL,et al.Sublytic C5b-9-stimulated Schwann cell survival through PI 3-kinase-mediated phosphorylation of BAD.Glia,2001,36(1):58.
[11] Niculescu F,Rus H.Complement activation and atherosclerosis.Mol Immunol,1999,36(13-14):949.
[12] Tanhehco EJ,Lee H,Lucchesi BR.Sublytic complement attack reduces infarct size in rabbit isolated hearts:evidence for C5a-mediated cardioprotection.Immunopharmacology,2000,49(3):391.
[13] Kraus S,Seger R,Fishelson Z.Involvement of the ERK mitogen-activated protein kinase in cell resistance to complement-mediated lysis.Clin Exp Immunol,2001,123(3):366.
[14] Kraus S,Fishelson Z.Cell desensitization by sublytic C5b-9 complexes and calcium ionophores depends on activation of protein kinase C.Eur J Immunol,2000,30(5):1272.
[15] Hed J.Role of complement in immune or idiopathic thrombocytopenic purpura.Acta Paediatr Suppl,1998,424:37., 百拇医药(郭 伟 李惠翔)